The Diabetic Foot



The Diabetic Foot


David E. Oji

Lew C. Schon



INTRODUCTION

Far from being just a foot problem, the patient with diabetes mellitus requires an integrated multidisciplinary approach to address every problem that can arise from the many systemic manifestations. Management requires treatment from many providers such as orthotists, nurse educators, dietitians, and physical therapists as well as expertise from other disciplines such as vascular surgery, endocrinology, infectious diseases, and neurology. The foot is a complex target of this multisystem disease, with disastrous consequences if the labor-intensive treatments do not adequately resolve its manifestations and complications in the lower extremity. The spectrum of clinical manifestations can range from mild neuropathy to severe ulcerations, infections, vasculopathy, Charcot arthropathy, and neuropathic fractures.


PATHOGENESIS


Epidemiology

The number of individuals affected by diabetes and its cost to society are staggering. The Center for Disease Control estimates that 8.3% of the general population, or 25.8 million people in the United States, are affected by diabetes, costing the healthcare system close to $174 billion in direct and indirect costs. Amputations among patients with diabetes are the leading cause of nontraumatic amputations. In 2006 alone, close to 65,700 amputations were performed among patients with diabetes. Instituting a comprehensive foot care program comprising risk assessment, foot care education, preventative care, and referral to specialists is believed to be able to reduce amputation rates by 45% to 85%.1 One study demonstrated an incidence of foot pathology among patients with diabetes in a medical clinic to be 68%, with manifestations ranging from callus formation, hammer toes, and peripheral and autonomic neuropathy.2



ULCERATONS


INTRODUCTION

Ulcerations in the diabetic foot result from continued pressure in the setting of neuropathy. The long-term cost of ulceration care is high owing to the patient’s need for home care and social services in the setting of recurrent lesions and the need for new amputations.20 Often ulcers are the precursor to subsequent infections, and therefore, they should be treated aggressively.


PATHOGENSIS


Epidemiology

The average annual incidence of new diabetic foot ulcerations was found to be 2.2%.21 Risk factors for the development of diabetic ulcerations are prior or current ulcerations; abnormal neuropathy disability score comprising changes
in vibratory, temperature, and pin prick perceptions; abnormal Achilles reflex; previous podiatric attendance; insensitivity to 10 g monofilament; reduced pulses; foot deformities; increased age; and abnormal ankle reflexes. Of these risk factors, prior or current ulcers, abnormal neuropathy disability score, and prior podiatric attendance were found to be highest risk factors for new foot ulcers. A combination of 10 g monofilament, neuropathy disability score, and palpation of foot pulses were recommended as a screening tool in general practice.21



Classification

Meggitt21a and Wagner15,21b described six grades of lesions that are seen in diabetic foot lesions (Table 5.1). Another commonly used classification is the depth-ischemia classification22— a modification of the original Meggitt-Wagner classification separating evaluation of the foot lesion and vascular perfusions (Table 5.2 and Figs. 5.3,Figs. 5.4,Figs. 5.5 and Figs. 5.6).




INFECTIONS


PATHOGENESIS


Epidemiology

Diabetic foot infections are commonly polymicrobial, with various combinations of organisms, although single-source infection can occur. Common organisms include Grampositive cocci such as staphylococci, group B streptococci, and enterococci; Gram-negative aerobic rods (Escherichia coli, Enterobacter, Proteus, Pseudomonas); and anaerobes (Bacteroides fragilis, Clostridium, Bacteroides). Of the organisms listed, the most common is Staphylococcus aureus, Streptococcus species, and Enterococcus species. However, it is important to remember that one-third of diabetic foot infections test positive for anaerobes in addition to other organisms.4,7





CHARCOT ARTHROPATHY


INTRODUCTION

Charcot neuroarthropathy is a progressive disease associated with deterioration of weight-bearing joints that occurs most commonly in the foot and ankle. Charcot arthropathy was first described by Jean Martin Charcot34 in 1868. Initially associated with tabes dorsalis infection, Jordan35 recognized the association between Charcot and diabetes mellitus in 1936. In 1958, Jacobs36 recognized that early and frequent radiographs are needed to follow the pathology closely in patients with diabetes, especially in those with concurrent ulcers. Currently, diabetes mellitus is the leading cause of the neuroarthropathy.


PATHOGENSIS


Epidemiology

The incidence of Charcot arthropathy has been estimated to be 1% to 37% among the diabetic population. A retrospective review of 456 patients with diabetes in 1997 noted radiographic changes of Charcot joint in 1.4% of patients.36a However, it is important to note that the rate of Charcot arthropathy has been increasing compared with older studies, which could be attributed either to an actual increase in the incidence of the disease or to increased awareness among treating physicians. Rates among men and women are similar. Approximately 30% of patients have bilateral involvement.7

Tags:
Aug 28, 2016 | Posted by in ORTHOPEDIC | Comments Off on The Diabetic Foot

Full access? Get Clinical Tree

Get Clinical Tree app for offline access